# Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease

> **NCT00364676** · PHASE1 · COMPLETED · sponsor: **Spectrum Pharmaceuticals, Inc** · enrollment: 67 (actual)

## Conditions studied

- Tumors
- Hodgkins Disease
- Non-Hodgkins Lymphoma

## Interventions

- **DRUG:** VLI
- **DRUG:** VLI

## Key facts

- **NCT ID:** NCT00364676
- **Lead sponsor:** Spectrum Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2015-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364676, "Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00364676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*